Reference(s)
Click here to return to the Reference Table

Category: Soft tissue sarcomas
Descriptor: Therapeutic Development


Reference Number: 1274
Wagner AJ, Goldberg JM, Dubois SG, Choy E, Rosen L, Pappo A, Geller J, Judson I, Hogg D, Senzer N, Davis IJ, Chai F, Waghorne C, Schwartz B, Demetri GD. Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial. Cancer. 118, 5894-902 (2012)
PubMed link      E-mail link